Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Deciphering the basis of mis-regulation of the miR17-92 cluster maturation in breast cancer

EF 2009-10

Résumé
Breast cancer is the number one cause of death of women in Canada. In the later years several genes had been discovered to act as oncogenes (cancer causing) or tumor suppressors. Those genes are generally transcription or translation factors that upregulate or downregulate the transcription (DNA to mRNA) or translation (mRNA to protein) respectively of target genes that increase (for oncogenes) or decrease (tumor suppressors) cell proliferation. In the last decade a new kind of player in the gene regulation landscape have been discovered that are very important for carcinogenesis. MicroRNAs (miRNAs) are small RNA molecules that are not translated to proteins. Those miRNA serve important functions in regulating gene expression. They generally inhibit translation by base paring with a target mRNA. Because they are able to regulate gene expression they can act as oncogenes and tumor suppressors. Some miRNAs are transcribed as a group and called miRNA clusters or polycistrons. Those polycistrons then mature to individual miRNAs by the action of the Drosha and Dicer proteins, and their associated partners. In mammals, the polycistron miR17-92 and its individual miRNAs have been shown to act as oncogenes in some forms of lymphoma and as tumor suppressors in breast cancer. The project will consist of measuring if the members of the polycistron are differently expressed at different stages of maturations in normal and breast cancer cells. If differences are found we will inquire if the enzymes Drosha and Dicer are aberrantly expressed or modified in those cells. This study will help to understand how miRNAs are missregulated in cancer (especially breast cancer), an important step to understand how tumor formation (tumorigenesis) occurs and to find novel therapies to treat breast cancer.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
199670
Name
Donayo Ariel O
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Deciphering the basis of mis-regulation of the miR17-92 cluster maturation in breast cancer
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Dicer; Drosha; Genetic Interaction; Mirna; Mirna Clusters; Mirna Regulation; Oncogenes; Small Rnas; Stromal Cells
Abstract
Breast cancer is the number one cause of death of women in Canada. In the later years several genes had been discovered to act as oncogenes (cancer causing) or tumor suppressors. Those genes are generally transcription or translation factors that upregulate or downregulate the transcription (DNA to mRNA) or translation (mRNA to protein) respectively of target genes that increase (for oncogenes) or decrease (tumor suppressors) cell proliferation. In the last decade a new kind of player in the gene regulation landscape have been discovered that are very important for carcinogenesis. MicroRNAs (miRNAs) are small RNA molecules that are not translated to proteins. Those miRNA serve important functions in regulating gene expression. They generally inhibit translation by base paring with a target mRNA. Because they are able to regulate gene expression they can act as oncogenes and tumor suppressors. Some miRNAs are transcribed as a group and called miRNA clusters or polycistrons. Those polycistrons then mature to individual miRNAs by the action of the Drosha and Dicer proteins, and their associated partners. In mammals, the polycistron miR17-92 and its individual miRNAs have been shown to act as oncogenes in some forms of lymphoma and as tumor suppressors in breast cancer. The project will consist of measuring if the members of the polycistron are differently expressed at different stages of maturations in normal and breast cancer cells. If differences are found we will inquire if the enzymes Drosha and Dicer are aberrantly expressed or modified in those cells. This study will help to understand how miRNAs are missregulated in cancer (especially breast cancer), an important step to understand how tumor formation (tumorigenesis) occurs and to find novel therapies to treat breast cancer.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Donayo, Ariel O
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~